Moderna, the maker of the second COVID-19 vaccine to see emergency use approval in the U.S., is now looking to create a dual vaccine against the flu and the novel virus, the company’s chief executive recently said.
Moderna, the maker of the second COVID-19 vaccine to see emergency use approval in the U.S., is now looking to create a dual vaccine against the flu and the novel virus, the company’s chief executive recently said.
